Article Details

Key Analysts at Barclays Maintain their '”Equal-Weight”' rating for PTC Therapeutics (NASDAQ ...

Retrieved on: 2018-03-08 03:30:00

Tags for this article:

Click the tags to see associated articles and topics

Key Analysts at Barclays Maintain their '”Equal-Weight”' rating for PTC Therapeutics (NASDAQ .... View article details on hiswai:

Excerpt

<div><b>Aqr Capital Management</b> Ltd Limited Liability Company reported 73,614 shares stake. Sei Invests Com invested 0% of its portfolio in PTC Therapeutics, Inc. (NASDAQ:PTCT). Royal Savings Bank Of Canada holds 10,972 shares or 0% of its portfolio. Prudential Finance accumulated 51,227 shares.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up